New 1-phthalazinone Scaffold based Compounds: Design, Synthesis, Cytotoxicity and Protein Kinase Inhibition Activity

Author(s): Nehad E. Abo-elmagd, Riham F. George, Manal A. Ezzat, Reem K. Arafa*.

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 18 , Issue 20 , 2018

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background & Method: A series of thirty-one new 1-phthalazinones was designed and synthesized based on the well-known VEGFR inhibitor vatalanib. The obtained phthalazinones were screened for their cytotoxic activity against DLD-1 and LoVo (colon), and Panc-1 and Paca-2 (pancreas) cancer cell lines using MTT assay. The tested compounds revealed exceptionally promising cytotoxic activity against LoVo cell lines with IC50 ranges 0.18-780 nM.

Conclusion: Finally, these compounds were also found to be dual inhibitors of VEGFR-2 and EGFR in the in vitro enzyme assay with higher potency against the former (IC50 = 0.023-0.41 nM).

Keywords: Cytotoxicity, EGFR, 1-Phthalazinone, VEGFR-2, xenograft, Cancer.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 18
ISSUE: 20
Year: 2018
Page: [1759 - 1774]
Pages: 16
DOI: 10.2174/1389557518666180903153254
Price: $58

Article Metrics

PDF: 24
HTML: 3